Lamisil


Also found in: Thesaurus, Medical, Wikipedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Lamisil - an oral antifungal drug (trade name Lamisil) used to treat cases of fungal nail disease
antifungal, antifungal agent, antimycotic, antimycotic agent, fungicide - any agent that destroys or prevents the growth of fungi
brand, brand name, marque, trade name - a name given to a product or service
References in periodicals archive ?
Two weeks of terbinafine (Lamisil) appears sufficient in cases due to Trichophyton.
It recently announced plans to develop and market a generic hormone-replacement product with PII (Hunt Valley, Md.), and a liquid generic ANDA product with Midland HealthCare (Kansas City, Kan.) It also announced plans to collaborate with international companies Orbus Pharma (Markham, Ontario) to market metoprolol succinate extended-release tablets, and Chemo/Liconsa (Madrid) to develop and manufacture terbinafine (Lamisil) tablets.
Lamisil, a product of Novartis Consumer Health Inc., claims a 14.3% dollar share of the category, followed by Schering-Plough HealthCare Products Inc.'s Lotrimin AF with 11.8% and Tinactin in third place with 10.8%.
Separately, the FDA has approved the first generic versions of prescription Lamisil (terbinafine hydrochloride tablets), used to treat nail fungus infection (onychomycosis).
Terbinafine solution (Lamisil) is an effective topical agent with about a 70% cure rate.
In 2007 Novartis has introduced five new products: Excedfin Back & Body, Lamisil Gel, Baby Gas-X Infant Drops, Maalox Junior and Maalox Children's.
Lamisil AT and Desenex are available from Novartis Consumer" Health Inc., and Micatin is a Pfizer Inc.
While Schefing-Plough HealthCare Products Inc.'s Lotrimin and Tinactin items and Novartis Pharmaceuticals Corp.'s Lamisil continue to lead in sales, several competitors are bringing a number of innovative items to the category.
The prevention approach also is being highlighted by Novartis Consumer Health Inc.'s category-leading Lamisil AT antifungal medication, which registered a 13.9% sales gain.
The next shelf includes such popular items as Flexitol Heel Balm and Novartis Pharmaceuticals Corp.'s Lamisil spray pump for athlete's feet.
Scholl's brand, and Novartis Consumer Health Inc.'s Lamisil antifungal medication helped raise the bar on the prices that consumers will pay in the two foot care segments.
The Novartis O-T-C business has delivered strong growth in recent years, achieving net sales of about $2 billion in 2004, primarily the result of focusing on seven global strategic brands: the anti-inflammatory agent Voltaren, antifungal cream Lamisil, smoking cessation product Nictonell, mineral supplement Calcium Sandoz, cough/cold therapy Theraful/NeoCitran, fiber supplement Benefiber and nasal decongestant Otrivin.